Key facts
- Notable investors include Creative Destruction Lab, Panache Ventures, IQ Capital Partners, OpenOcean (Helsinki), Ellipsis Venture.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for DreamFold
- ·The full record, as it builds
Funding rounds
No funding rounds for DreamFold are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About DreamFold
Developer of generative machine learning algorithms intended to navigate the vast space of proteins to discover medicines. The company's biotechnology is based on generative flow networks, active learning, and designing antibodies that target membrane proteins and transmit the signal directly into the diseased cell, helping healthcare professionals to cure devastating diseases such as diabetes and cancer.
- Sector
- Healthcare
- HQ
- Palo Alto, CA, United States
- Founded
- 2021
- Employees
- 10
- Website
- dreamfold.ai/
- Ownership
- Privately Held (backing)
DreamFold doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in DreamFold shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on DreamFold in its N-PORT filings yet. We sweep new filings monthly.